학술논문
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
Document Type
Article
Author
Source
In: Arthritis research & therapy . (Arthritis research & therapy, 2005, 7(6):R1281-1288)
Subject
Language
English
ISSN
14786362